ESTRELLA IMMUNOPHARMA, INC. Related Party Transaction, Amounts of Transaction
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Related Party Transaction, Amounts of Transaction of $1.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2026-08-13
- ESTRELLA IMMUNOPHARMA, INC. related party transaction, amounts of transaction for the quarter ending 2026-06-30 was $1.44M, a 69.34% decline year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. related party transaction, amounts of transaction for the quarter ending 2026-03-31 was $1.44M, a 0.38% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. related party transaction, amounts of transaction for the quarter ending 2025-06-30 was $4.69M.
- ESTRELLA IMMUNOPHARMA, INC. related party transaction, amounts of transaction for the quarter ending 2025-03-31 was $1.44M.
- ESTRELLA IMMUNOPHARMA, INC. related party transaction, amounts of transaction for fiscal 2025 was $10.39T.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|
| 2026-06-30 | $1.44M 10-Q · filed 2026-08-13 | $2.88M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.44M 10-Q · filed 2026-05-18 | ||
| 2025-12-31 | $10.39T 10-K · filed 2026-03-18 | ||
| 2025-06-30 | $4.69M 10-Q · filed 2026-08-13 | $6.13M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $1.44M 10-Q · filed 2026-05-18 | ||
| 2024-12-31 | $2.91T 10-K · filed 2026-03-18 | ||
| 2023-09-29 | $1.64M 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |